Clinical trial Recruiting at 1 site Interventional Ages 14 to 16 Women only

Whole-Body Vibration and Relaxation for Adolescent Girls with Triad

Official title: The Impact of Whole-Body Vibration and Relaxation Techniques on Adolescent Athlete Girls With Triad Syndrome"

Run by MTI University · NCT07587346 · Data updated 2026-11-12

This study tests whether a program of whole-body vibration plus relaxation can help improve bone health, periods, and well-being in adolescent female athletes with Female Athlete Triad Syndrome.

More Menstrual Cycle trials

Quick facts

Study typeInterventional
Ages14 Years to 16 Years
SexWomen only
Enrollment50 (estimated)
SponsorMTI University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedNovember 2, 2025
Main results expectedJanuary 2, 2026
Study endsMay 22, 2026
Registry record updatedMay 14, 2026
Trial IDNCT07587346 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adolescent female athletes with low energy availability, menstrual dysfunction, and low bone density or a history of stress fractures.

Probably not a fit

Individuals without low energy availability or without indicators of bone health impact may see little benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial examines the effects of a structured 8-week program combining whole-body vibration training and relaxation techniques in adolescent female athletes diagnosed with Female Athlete Triad Syndrome. Participants are randomized to receive WBV plus relaxation versus relaxation alone, under physiotherapist supervision. Primary outcomes include changes in bone mineral density and hormonal regulation, with secondary outcomes focusing on psychological well-being and physical performance. The study aims to determine if adding WBV to relaxation can support bone health, menstrual function, and overall recovery in this population.

Why it matters

Potential benefit: If successful, the approach could help improve bone health and menstrual regularity, along with better overall well-being for affected athletes.

How similar studies have gone: Prior research has explored WBV in bone health contexts, with mixed results; this combination with relaxation is relatively novel in this specific population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Low energy availability (with or without disordered eating)
* Menstrual dysfunction (oligomenorrhea)
* Low bone mineral density or a history of stress fractures

Exclusion criteria:

* Recent fractures or unhealed stress fractures within the last 6 months.
* Presence of serious medical conditions that contraindicate WBV or exercise participation, such as: Uncontrolled cardiovascular disease, Uncontrolled hypertension, Neurological disorders, Severe vestibular disorders, Active cancer, Bleeding/clotting disorders.
* Severe eating disorder requiring inpatient medical or psychiatric treatment.
* Current use of medications that significantly affect bone or hormonal status
* Participation in another interventional clinical study within the last 3 months.
* Inability or unwillingness to provide assent/consent or comply with study procedures.

Where it's running

  • Mti
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.